Q2 2024 · 13F-HR
Blue Owl Capital Holdings LPholdings as filed
Filed 2024-08-15 · accession 0000950123-24-008845
$359.6M
Reported value
41
Positions
2024-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 230031106 | CGEM | CULLINAN THERAPEUTICS INC | $35.7M | 9.94% | 2,049,172 | Common | SOLE |
| 729139105 | PLRX | PLIANT THERAPEUTICS INC | $32.3M | 8.98% | 3,004,199 | Common | SOLE |
| 69121K104 | OBDC | BLUE OWL CAPITAL CORPORATION | $31.4M | 8.74% | 2,045,070 | Common | SOLE |
| 49845K101 | KVYO | KLAVIYO INC | $29.8M | 8.29% | 1,198,270 | Common | SOLE |
| 517125100 | LRMR | LARIMAR THERAPEUTICS INC | $28.0M | 7.78% | 3,859,468 | Common | SOLE |
| 29286M105 | — | ENGENE HOLDINGS INC | $23.1M | 6.43% | 2,449,827 | Common | SOLE |
| 89157D105 | TRML | TOURMALINE BIO INC | $22.1M | 6.14% | 1,715,401 | Common | SOLE |
| 29977X105 | EVCM | EVERCOMMERCE INC | $18.0M | 5.01% | 1,641,929 | Common | SOLE |
| 00445A100 | — | ACELYRIN INC | $12.9M | 3.59% | 2,926,028 | Common | SOLE |
| 760273102 | RPTX | REPARE THERAPEUTICS INC | $11.1M | 3.10% | 3,372,499 | Common | SOLE |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $11.0M | 3.07% | 268,238 | Common | SOLE |
| 21077P108 | CNTX | CONTEXT THERAPEUTICS INC | $10.3M | 2.88% | 5,161,290 | Common | SOLE |
| 254604101 | IRON | DISC MEDICINE INC | $9.7M | 2.70% | 215,260 | Common | SOLE |
| 888787108 | TOST | TOAST INC | $8.3M | 2.31% | 322,578 | Common | SOLE |
| 29788T103 | ETWOGBP | E2OPEN PARENT HOLDINGS INC | $7.4M | 2.06% | 1,650,943 | Common | SOLE |
| 492327101 | KROS | KEROS THERAPEUTICS INC | $7.2M | 2.00% | 157,633 | Common | SOLE |
| 45175G108 | — | IKENA ONCOLOGY INC | $6.8M | 1.88% | 4,091,118 | Common | SOLE |
| 786700104 | SGMT | SAGIMET BIOSCIENCES INC | $5.7M | 1.59% | 1,673,877 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $5.3M | 1.47% | 450,339 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $5.0M | 1.40% | 95,000 | Common | SOLE |
| 45790W108 | — | INOZYME PHARMA INC | $5.0M | 1.39% | 1,120,027 | Common | SOLE |
| 85571B105 | STWD | STARWOOD PROPERTY TRUST | $4.3M | 1.19% | 226,456 | Common | SOLE |
| 747324101 | PYXS | PYXIS ONCOLOGY INC | $3.5M | 0.96% | 1,046,025 | Common | SOLE |
| 589492107 | MREO | MEREO BIOPHARMA GROUP PLC | $3.2M | 0.90% | 897,809 | Common | SOLE |
| 03843E104 | AQST | AQUESTIVE THERAPEUTICS INC | $3.0M | 0.82% | 1,140,000 | Common | SOLE |
| 20454B104 | CMPX | COMPASS THERAPEUTICS INC | $2.8M | 0.79% | 2,829,712 | Common | SOLE |
| H0036K147 | ADCT | ADC THERAPEUTICS SA | $2.3M | 0.64% | 733,568 | Common | SOLE |
| 68217N105 | — | OMEGA THERAPEUTICS INC | $2.2M | 0.61% | 1,055,882 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $2.2M | 0.60% | 55,000 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $2.1M | 0.59% | 80,000 | Common | SOLE |
| 87184Q206 | SYRS | SYROS PHARMACEUTICALS INC | $1.8M | 0.49% | 340,855 | Common | SOLE |
| 47103J105 | JANX | JANUX THERAPEUTICS INC | $1.7M | 0.47% | 40,000 | Common | SOLE |
| 15102K100 | CELC | CELCUITY INC | $1.1M | 0.30% | 65,000 | Common | SOLE |
| 09352U108 | BLND | BLEND LABS INC | $853,351 | 0.24% | 361,587 | Common | SOLE |
| 38046W204 | GOCO | GOHEALTH INC | $814,631 | 0.23% | 83,264 | Common | SOLE |
| 29286M113 | — | ENGENE HOLDINGS INC | $608,301 | 0.17% | 51,177 | Common | SOLE |
| G63290129 | PLMUF | PLUM ACQUISITION CORP III | $324,001 | 0.09% | 70,000 | Common | SOLE |
| 25058X303 | DM* | DESKTOP METAL INC | $309,750 | 0.09% | 750,000 | Common | SOLE |
| 74019P207 | DTIL | PRECISION BIOSCIENCES INC | $196,741 | 0.05% | 20,220 | Common | SOLE |
| 374163103 | GERN | GERON CORPORATION | $101,412 | 0.03% | 23,918 | Common | SOLE |
| G63290103 | PLMWF | PLUM ACQUISITION CORP III | $46,667 | 0.01% | 666,666 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.